Kinnate Biopharma (KNTE) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Kinnate Biopharma.
Bought (12 mo)
$0
Sold (12 mo)
$0
Insiders Buying (12 mo)
0
Insiders Selling (12 mo)
0
Form 4 Filings (All Time)
81
Most Recent Purchase
May 10, 2023
James B. Tananbaum
Director
$4,984,000
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|
Sign up free to view more insider trades.